SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007065
Filing Date
2022-05-04
Accepted
2022-05-04 16:32:59
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20220331x10q.htm   iXBRL 10-Q 1838762
2 EX-10.3 vygr-20220331xex10d3.htm EX-10.3 565936
3 EX-31.1 vygr-20220331xex31d1.htm EX-31.1 12995
4 EX-31.2 vygr-20220331xex31d2.htm EX-31.2 12984
5 EX-32.1 vygr-20220331xex32d1.htm EX-32.1 10715
6 GRAPHIC vygr-20220331x10q006.jpg GRAPHIC 70479
  Complete submission text file 0001558370-22-007065.txt   7190267

Data Files

Seq Description Document Type Size
7 EX-101.SCH vygr-20220331.xsd EX-101.SCH 47103
8 EX-101.CAL vygr-20220331_cal.xml EX-101.CAL 42379
9 EX-101.DEF vygr-20220331_def.xml EX-101.DEF 192374
10 EX-101.LAB vygr-20220331_lab.xml EX-101.LAB 382540
11 EX-101.PRE vygr-20220331_pre.xml EX-101.PRE 304968
56 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20220331x10q_htm.xml XML 946517
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 22892047
SIC: 2836 Biological Products, (No Diagnostic Substances)